Jiandong Xu Biography and Net Worth

CFO of Estrella Immunopharma

Mr. Xu is the Chief Financial Officer of Estrella Biopharma. Mr. Xu has 15 years investment and management experience in capital markets, energy markets and food & beverage industry.

Prior to joining Estrella Biopharma, he has been the founder and CEO of TLC Gourmet Food International LLC since 2021. He has also served as the co-founder and CEO of Lake Crystal Energy LLC since 2020. Previously, Mr. Xu founded LI North Shore Invest LLC where he invests and manages a portfolio of small businesses since 2017. Prior to that, he held various investment and management positions at Millennium Partners, Barclays Capital, and Lehman Brothers. Mr. Xu earned a MS degree in Computer Science from Northeastern University in Boston.

What is Jiandong Xu's net worth?: The estimated net worth of Jiandong Xu is at least $134.94 thousand as of September 11th, 2025. Mr. Xu owns 264,588 shares of Estrella Immunopharma stock worth more than $134,940 as of October 1st. This net worth estimate does not reflect any other assets that Mr. Xu may own. Learn More about Jiandong Xu's net worth.
How do I contact Jiandong Xu?: The corporate mailing address for Mr. Xu and other Estrella Immunopharma executives is 5858 Horton Street, Suite 370, Emeryville, CA, 94608. Estrella Immunopharma can also be reached via phone at 510-318-9098 and via email at [email protected]. Learn More on Jiandong Xu's contact information.
Has Jiandong Xu been buying or selling shares of Estrella Immunopharma?: Jiandong Xu has not been actively trading shares of Estrella Immunopharma during the last ninety days. Most recently, on Tuesday, October 7th, Jiandong Xu bought 1,000 shares of Estrella Immunopharma stock. The stock was acquired at an average cost of $1.33 per share, with a total value of $1,330.00. Following the completion of the transaction, the chief financial officer now directly owns 265,488 shares of the company's stock, valued at $353,099.04. Learn More on Jiandong Xu's trading history.
Are insiders buying or selling shares of Estrella Immunopharma?: During the last year, Estrella Immunopharma insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $1,330.00. The most recent insider tranaction occured on October, 7th when CFO Jiandong Xu bought 1,000 shares worth more than $1,330.00. Insiders at Estrella Immunopharma own 5.8% of the company. Learn More about insider trades at Estrella Immunopharma.
Information on this page was last updated on 10/7/2025.

Jiandong Xu Insider Trading History at Estrella Immunopharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/7/2025	Buy	1,000	$1.33	$1,330.00	265,488
9/22/2025	Buy	1,000	$1.16	$1,160.00	16,700
9/11/2025	Buy	100	$1.04	$104.00	264,588

Jiandong Xu Buying and Selling Activity at Estrella Immunopharma

Estrella Immunopharma Company Overview

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Today's Range

Now: $0.47

$0.46

$0.48

50 Day Range

MA: $0.66

$0.43

$0.78

2 Week Range

Now: $0.47

$0.43

$3.15

Volume

12,593 shs

Average Volume

97,117 shs

Market Capitalization

$20.23 million

P/E Ratio

N/A

Dividend Yield